Lexin Technology's daily limit of 20cm today was 192 million yuan, and Lexin Technology's daily limit was 20cm today, with a turnover of 2.799 billion yuan and a turnover rate of 12.22%. After-hours data showed that the special seats of Shanghai Stock Connect bought 215 million yuan and sold 226 million yuan, and the special seats of the two institutions sold 192 million yuan.According to the short-distance mode of Pudong Airport, Shanghai Hongqiao Hub will open a fast lane for short-distance taxis. On December 11th, the reporter learned from the Shanghai Transportation Department that in order to improve the overall service quality of taxis in Hongqiao Hub area and actively respond to drivers' concerns about waiting time, Shanghai Hongqiao Hub area will refer to the short-distance mode of Pudong Airport, and take the automatic comparison and identification of the system as the basis for identification. Cruise taxis that meet the short-distance conditions can directly go to the pick-up point through the short-distance fast dedicated lane. At present, the rental stations of Hongqiao Hub (Hongqiao Railway Station, Hongqiao Airport T2) have erected signs with the words "for short-distance return" respectively. (CCTV News)On the 11th, the European futures of the container freight index fell by 3.66%, and the latest main contract positions changed as follows. According to the data of the exchange, as of December 11th, the European futures of the main contract container freight index closed at 2502, up or down by -3.66%, with a turnover of 38,900 lots. The position data showed that the top 20 seats were net, and the difference position was 2,373 lots. The total number of European futures contracts of container transport index was 91,300 lots, an increase of 23,900 lots over the previous day. The first 20 seats in the contract held 26,100 lots, an increase of 794 lots over the previous day. Short positions in the top 20 seats of the contract were 23,700 lots, an increase of 757 lots over the previous day. (Sina Futures)
AMD Lisa Su was named CEO of the Year by Time magazine, and Time magazine published a blog post yesterday (December 10th) to select lisa su, CEO of AMD, as "CEO of 2024". The blog post tells the story of how lisa su led the company to turn losses into profits and challenged the giant NVIDIA in the field of artificial intelligence chips.Robot concept stocks are active again and again, and Great Wheel Intelligence, Ningbo Jingda, Kelier and Keli Sensing have reached new heights.UBS: It is estimated that by 2025, the price of Brent crude oil will rise to $80/barrel and WTI crude oil will rise to $75/barrel. Have a constructive view on the prospect of natural gas price in 2025 (the forecast is $3.50/million British heat in June and $3.60/million British heat in September).
Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee. According to the news of Changzhi News VideoNo. on December 11th, Changzhi held a meeting of leading cadres in the whole city. The meeting announced the decision of the provincial party committee, and Comrade Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
Strategy guide
Strategy guide
12-14
Strategy guide
Strategy guide
12-14